Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

American Journal of Rhinology

Volumn 14, Issue 3, 2000, Pages 143-148

  Yamada, Takechiyo ^a,b   Fujieda, Shigeharu ^a   Mori, Shigehito ^a   Yamamoto, Hideyuki ^a   Saito, Hitoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 8; MACROLIDE;

ADULT; AGED; ARTICLE; BRONCHIOLITIS; CHRONIC BRONCHITIS; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; LUNG FUNCTION; MALE; NOSE POLYP; TREATMENT OUTCOME;

EID: 0033947534     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065800782102717     Document Type: Article

References (31)

1. Nagai H, Shishido H, Yoneda R, et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 58:145-149, 1991.
2. Ichikawa Y, Ninomiya H, Koga H, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 146:196-203, 1992.
3. Sakito O, Kadota J, Kohno S, et al. Interteukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 63:42-48, 1996.
4. Tsang KW, Ho PI, Chan KN, et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 13:361-364, 1999.
5. Hoiby N. Diffuse panbronchiolitis and cystic fibrosis: East meets West Thorax 49:531-532, 1994.
6. Jaffe A, Francis J, Rosenthal M, et al. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 351:420, 1998.
7. Hashiba M, and Baba S. Efficacy of long-term administration of clanthromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Stockh 525(Suppl):73-78, 1996.
8. Mukaida N, Shiroo M, and Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143:1366-1371, 1989.
9. Djeu JY, Matsushima K, Oppenheim JJ, et al. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 144:2205-2210, 1990.
10. Yuo A, Kitagawa S, Kasahara T, et al. Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood 78:2708-2714, 1991.
11. Takeuchi K, Yuta A, Sakakura, Y, et al. Interleukin-8 gene expression in chronic sinusitis. Am J Otolaryngol 16:98-102, 1995.
12. Suzuki H, Takahashi Y, Wataya H, et al. Mechanism of neutrophil recruitment induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 98:659-670, 1996.
13. Allen JS, Eisma R, Leonard G, et al. Interleukin-8 expression in human nasal polyps. Otolaryngol Head Neck Surg 117:535-541, 1997.
14. Suzuki H, Shimomura A, Ikeda K, et al. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells. Laryngoscope 107:1661-1666, 1997.
15. Diaz-Sanchez D, Dotson AR, Takenaka H, et al. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 94:1417-1425, 1994.
16. Fujieda S, Diaz-Sanchez D, and Saxon A. Combined nasal challenge with diesel exhaust particles and allergen induces in vivo IgE isotype switching. Am J Respir Cell Mol Biol 19:507-512, 1998.
17. Buehring I, Friedrich B, Schaaf J, et al. Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. Clin Exp Immunol 109:468-472, 1997.
18. Demoly P, Crampette L, Mondain M, et al. Myeloperoxidase and interleukin-8 levels in chronic sinusitis. Clin Exp Allergy 27: 672-675, 1997.
19. Turner RB, Weingand KW, Yeh CH, et al. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis 26:840-846, 1998.
20. Krakauer T. Interleukin-8 production by human monocytic cells in response to staphylococcal exotoxins is direct and independent of interleukin-1 and tumor necrosis factor-alpha. J Infect Dis 178:573-577, 1998.
21. Jacobi HH, Poulsen LK, Reimert CM, et al. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge. Int Arch Allergy Immunol 116:53-59, 1998.
22. Park HS, Jung KS, Hwang SC, et al. Neutrophil infiltration and release of IL-8 in airway mucosa from subjects with grain dust-induced occupational asthma. Clin Exp Allergy 28:724-730, 1998.
23. Gon Y, Hashimoto S, Matsumoto K, et al. Cooling and rewarming-induced IL-8 expression in human bronchial epithelial cells through p38 MAP kinase-dependent pathway. Biochem Biophys Res Commun 249:156-160, 1998.
24. Ohtoshi T, Takizawa H, Okazaki H, et al. Diesel exhaust particles stimulate human airway epithelial cells to produce cytokines relevant to airway inflammation in vitro. J Allergy Clin Immunol 101:778-785, 1998.
25. Khair OA, Devalia JL, Abdelaziz MM, et al. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8a, IL-8 and sICAM-I by cultured human bronchial epithelial cells. Eur Respir J 8:1451-1457, 1995.
26. Tanaka C, Kamata H, Takeshita H, et al. Redox regulation of LPS-induced IL-8 gene expression mediated by NFκB and AP-I in human astrocytoma U373 cells. Biochem Biophys Res Commun 232:568-573, 1997.
27. Sugita N, Kimura A, Matsuki Y, et al. Activation of transcription factors and IL-8 expression in neutrophils stimulated with lipopolysaccharide from porphyromonas gingivalis. Inflammation 22:253-267, 1998.
28. Suzuki H, Asada Y, Ikeda K, et al. Inhibitory effect of erythromycin on EL-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope 109:407-410, 1999.
29. Mygind N. Nasal polyposis. J Allergy Clin Immunol 86: 827-829, 1990.
30. Yanagihara K, Tomono K, Sawai T, et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 155:337-342, 1997.
31. Fujii T, Kadota J, Kawakami K, et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 50:1246-1252, 1995.